1.Suda T, Ueno Y, Fujii K, Shinki T. Vitamin D and bone. Journal of cellular biochemistry. 2003;88(2):259–66.
2.Yuan W, Pan W, Kong J, et al. 1, 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. Journal of Biological Chemistry. 2007;282(41):29821–30.
3.Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. British Journal of Nutrition. 2012;108(11):1915–23.
4.Lips P, Hosking D, Lippuner K, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. Journal of internal medicine. 2006;260(3):245–54.
5.Kazemi A, Sharifi F, Jafari N, Mousavinasab N. High prevalence of vitamin D deficiency among pregnant women and their newborns in an Iranian population. Journal of Women’s Health. 2009;18(6):835–9.
6.Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public health. 2004;4(1):1.
7.Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition. 2000;72(3):690–3.
8.Gannagé-Yared M-H, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. European Journal of Endocrinology. 2009;160(6):965–71.
9.Kelly A, Brooks LJ, Dougherty S, Carlow DC, Zemel BS. A cross-sectional study of vitamin D and insulin resistance in children. Archives of disease in childhood. 2011:archdischild187591.
10.Greer RM, Rogers MA, Bowling FG, et al. Australian children and adolescents with type 1 diabetes have low vitamin D levels. The Medical journal of Australia. 2007;187(1):59.
11.Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. The American journal of clinical nutrition. 2004;79(5):820–5.
12.Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes care. 2004;27(12):2813–8.
13.Labriji-Mestaghanmi H, Billaudel B, Garnier P, Malaisse W, Sutter BCJ. Vitamin D and pancreatic islet function I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. Journal of endocrinological investigation. 1988;11(8):577–84.
14.Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care. 2009;32(Supplement 1):S62-S7.
15.Zhang C, Qiu C, Hu FB, et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PloS one. 2008;3(11):e3753.
16.Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. The American journal of clinical nutrition. 1994;59(5):1083–7.
17.Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism. 2004;89(5):2306–11.
18.Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? Journal of molecular medicine. 2002;80(11):696–702.
19.Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta obstetricia et gynecologica Scandinavica. 2004;83(4):341–7.
20.Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1996;221:286–9.
21.Cnop M, Havel PJ, Utzschneider K, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459–69.
22.Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules. Circulation. 1999;100(25):2473–6.
23.Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884–8.
24.Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arteriosclerosis, thrombosis, and vascular biology. 2004;24(1):29–33.
25.Di Chiara T, Argano C, Corrao S, Scaglione R, Licata G. Hypoadiponectinemia: a link between visceral obesity and metabolic syndrome. Journal of nutrition and metabolism. 2011;2012.
26.de Luis DA, Soto GD, Conde R, Izaola O, de la Fuente B. Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. Journal of clinical laboratory analysis. 2012;26(5):398–402.
27.Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, thrombosis, and vascular biology. 2000;20(6):1595–9.
28.Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism. 2001;86(5):1930–5.
29.Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes. Diabetes Care. 2004;27(3):799–800.
30.Retnakaran R, Qi Y, Connelly P, Sermer M, Hanley A, Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia. 2010;53(2):268.
31.Belenchia AM, Tosh AK, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. The American journal of clinical nutrition. 2013;97(4):774–81.
32.Gagnon C, Daly RM, Carpentier A, et al. Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PloS one. 2014;9(10):e109607.
33.Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clinical nutrition. 2013;32(6):970–5.
34.Baziar N, Jafarian K, Shadman Z, Qorbani M, Nikoo MK, Mishani MA. Effect of Therapeutic Dose of Vitamin D on Serum adiponectin and glycemia in vitamin D-insufficient or deficient type 2 diabetic patients. Iranian Red Crescent Medical Journal. 2014;16(9).
35.Dinca M, Serban M-C, Sahebkar A, et al. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacological research. 2016;107:360–71.
36.Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. American journal of obstetrics and gynecology. 1982;144(7):768–73.
37.Schmidt MI, Duncan BB, Reichelt AJ, et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes care. 2001;24(7):1151–5.
38.Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266–81.
39.Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine & growth factor reviews. 2003;14(5):447–55.
40.Sun X, Zemel MB. Calcium and 1, 25‐dihydroxyvitamin D3 regulation of adipokine expression. Obesity. 2007;15(2):340–8.
41.Mousa A, Abell SK, Shorakae S, et al. Relationship between vitamin D and gestational diabetes in overweight or obese pregnant women may be mediated by adiponectin. Molecular Nutrition & Food Research. 2017.
42.Kardas F, Kendirci M, Kurtoglu S. Cardiometabolic risk factors related to vitamin d and adiponectin in obese children and adolescents. International journal of endocrinology. 2013;2013.
43.Minto C, Vecchio MG, Gregori D. Effects of vitamin D supplementation on serum adiponectin: a metaregression analysis of clinical trials. The FASEB Journal. 2015;29(1 Supplement):LB347.
44.Shargorodsky M, Boaz M, Goldberg Y, et al. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? International Journal of Obesity. 2009;33(5):553–8.
45.Vaidya A, Forman JP, Underwood PC, et al. The influence of body mass index and renin–angiotensin–aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. European journal of endocrinology. 2011;164(6):995–1002.
46.Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial. Diabetologia. 2014;57(9):1798–806.
47.Yap C, Cheung NW, Gunton JE, et al. Vitamin D supplementation and the effects on glucose metabolism during pregnancy: a randomized controlled trial. Diabetes Care. 2014;37(7):1837–44.
48.Mojibian M, Soheilykhah S, Zadeh MAF, Moghadam MJ. The effects of vitamin D supplementation on maternal and neonatal outcome: A randomized clinical trial. Iranian journal of reproductive medicine. 2015;13(11):687.
49.Lee S, Lee D-K, Choi E, Lee JW. Identification of a functional vitamin D response element in the murine Insig–2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes. Molecular endocrinology. 2005;19(2):399–408.
50.Asemi Z, Hashemi T, Karamali M, Samimi M, Esmaillzadeh A. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. The American journal of clinical nutrition. 2013;98(6):1425–32.
51.von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient–a randomised, placebo-controlled trial. British Journal of Nutrition. 2010;103(4):549–55.
52.McCarty M, Thomas C. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Medical hypotheses. 2003;61(5):535–42.
53.Vilarrasa N, Vendrell J, Maravall J, et al. Is plasma 25 (OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010;38(2):235–42.
54.Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: a pilot prospective randomized trial. Journal of diabetes. 2010;2(1):36–40.